Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 9/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.48 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.45 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.45 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.45 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359673 | 1.00 | SLC7A5 (0.50) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| SCHEMBL8368782 | 1.00 | SLC7A5 (0.50) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Glutamine SCHEMBL3192030 | 0.85 | ALOX15 (0.66) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| Glutamine SCHEMBL3192024 | 0.85 | ALOX15 (0.66) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| SCHEMBL9949059 | 0.82 | SLC7A5 (0.44) | SLC7A5GRIK1GRIK2GRM1GRM2 | |
| SCHEMBL12534395 | 0.81 | SLC1A3 (0.35) | GRIK1GRIK2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL21896210 | 0.81 | MCL1 (0.34) | SLC7A5GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL16280988 | 0.81 | SLC1A3 (0.35) | GRIK1GRIK2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15145068 | 0.81 | MCL1 (0.34) | SLC7A5GRIK1GRIK2SLC1A3SLC1A2 | |
| SCHEMBL13329918 | 0.80 | SLC7A5 (0.41) | SLC7A5GRIK1GRIK2SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| US-20250161408-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2025-05-22 | — | — | US | claimed |
| EP-4482852-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2025-01-01 | — | — | EP | claimed |
| EP-4464715-A2 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | BicycleTx Limited (GB) | 2024-11-20 | — | — | EP | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| WO-2023161211-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-31 | — | — | WO | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| EP-4230645-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2023-08-23 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| US-9101662-B2 | Compositions with modulating agents | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-08-11 | — | — | US | claimed |
| US-20150166606-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA PHARMACEUTICALS, INC. | 2015-06-18 | — | — | US | claimed |
| WO-2014194030-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2014-12-04 | — | — | WO | claimed |
| WO-2014134457-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2014-09-04 | — | — | WO | claimed |
| WO-2014134486-A2 | CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS | IMMUNOGEN, INC. (US) | 2014-09-04 | — | — | WO | claimed |
| US-8795693-B2 | Compositions with modulating agents | FOAMIX LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| US-20100163070-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBRES USING HEATING MEANS AND AN AMIDE | L'OREAL S.A. (FR) | 2010-07-01 | — | — | US | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | SLC7A5 2179/4885GRIK1 3907/4885GRIK2 4219/4885 |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | CUTA, SLTM, SMO | SLC7A5 4410/4885GRIK1 2104/4885GRIK2 2050/4885 |
| US-20150166606-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | KLKB1, KLK1, KLK5 | SLC7A5 2730/4885GRIK1 1016/4885GRIK2 1626/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | SLC7A5 196/4885GRIK1 3105/4885GRIK2 3847/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | SLC7A5 37/4885GRIK1 1721/4885GRIK2 2483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.